|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 04:56PM
|
|
Re: European Atherosclerosis Society Congress May 29 - June 1
|
3
|
Resverlogix Corp.
|
May 30, 2016 10:40AM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
3
|
Resverlogix Corp.
|
Mar 24, 2019 10:38AM
|
|
Re: Win or lose....one thing we know for sure
|
3
|
Resverlogix Corp.
|
Sep 02, 2019 06:36PM
|
|
Re: Biotech Showcase January 8-10, 2018
|
3
|
Zenith Epigenetics
|
Dec 28, 2017 02:23PM
|
|
Re: why I invested in Bioasis
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2020 12:26PM
|
|
Re: ZEN-3694 mCRPC Trial Status
|
3
|
Zenith Epigenetics
|
Oct 24, 2017 04:55PM
|
|
Re: AAIC and MD&A
|
3
|
Resverlogix Corp.
|
Jul 25, 2018 08:29PM
|
|
Re: I'm Bullish Again on RVX and ZENITH
|
3
|
Zenith Epigenetics
|
Apr 22, 2016 11:13AM
|
|
Re: BETonMACE Enrollment
|
3
|
Resverlogix Corp.
|
Aug 30, 2017 08:17PM
|
|
Bioasis Proactive Investors Interview with Dr. Deborah Rathjen
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jan 13, 2020 05:45PM
|
|
Re: BETonMACE USA vs. non-USA brainstorming
|
3
|
Resverlogix Corp.
|
Nov 20, 2017 07:16PM
|
|
Re: Denali Therapeutics unveils BBB delivery system
|
3
|
BIOASIS TECHNOLOGIES INC
|
May 28, 2020 12:46PM
|
|
Re: Questions on the last couple days of trading
|
3
|
Resverlogix Corp.
|
Mar 15, 2019 11:21AM
|
|
Re: RVX FILES ANNUAL INFO FORM
|
3
|
Resverlogix Corp.
|
Jul 27, 2015 09:34PM
|
|
Re: RRR %
|
3
|
Resverlogix Corp.
|
Jul 01, 2019 02:21PM
|
|
biOasis Enters Into a License Agreement With Vaccinex Inc.
|
3
|
BIOASIS TECHNOLOGIES INC
|
Sep 20, 2016 08:41PM
|
|
Bioasis Announces Allowance of Japanese Patent Application in Japan Relating to xB3TM Fusion Protein Comprising Iduronate-2-sulfatas...
|
3
|
BIOASIS TECHNOLOGIES INC
|
Aug 10, 2021 12:37PM
|
|
Re: AACR 2019
|
3
|
Zenith Epigenetics
|
Feb 28, 2019 08:33AM
|
|
Re: TRIALS SITE/ SHOWS TWO APPROVED TRIALS
|
3
|
Zenith Epigenetics
|
Jun 16, 2016 01:22PM
|
